Breakthrough Therapies: Failed Study Won’t Automatically Lead To Rescinded Designation

 
• By Sue Sutter and Bridget Silverman
  
Disappearing bridge
A breakthrough therapy designation won't automatically disappear if a subsequent study fails its efficacy endpoint. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards